Hims eyes growth in its weight loss business, despite end of semaglutide shortage
Hims & Hers expects revenue from its weight loss business to soar in 2025, even though a recent FDA move could make it tougher for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
